 Wall Street brokerages expect Stealth BioTherapeutics Corp NASDAQ:MITO to announce earnings of 0.02 per share for the current quarter, according to Zacks. Zero analysts have made estimates for Stealth BioTherapeutics earnings. Stealth BioTherapeutics reported earnings of 0.04 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 50. The ... 